Literature DB >> 4277685

The clinical incidence of myoclonus.

A M Halliday.   

Abstract

Entities:  

Mesh:

Year:  1967        PMID: 4277685

Source DB:  PubMed          Journal:  Mod Trends Neurol        ISSN: 0544-6872


× No keyword cloud information.
  9 in total

1.  Ocular bobbing and opsoclonus: two abnormal spontaneous eye movements occurring in the same patient: case report.

Authors:  H G Boddie
Journal:  J Neurol Neurosurg Psychiatry       Date:  1972-10       Impact factor: 10.154

2.  [A clinical and neurophysiological study of an uncommon myoclonic syndrome].

Authors:  K Meier-Ewert; E Schenck; W Kuhlo
Journal:  Dtsch Z Nervenheilkd       Date:  1969-10

3.  [A large family of Valais affected with progressive myoclonic epilepsy and retinitis pigmentosa. A clinical, genetical and anatomo-pathological study].

Authors:  D Klein; M Mumenthaler; R Kraus-Ruppert; E Rallo
Journal:  Humangenetik       Date:  1968

4.  Dyssynergia cerebellaris myoclonica (Ramsay Hunt syndrome): a condition unrelated to mitochondrial encephalomyopathies.

Authors:  C A Tassinari; R Michelucci; P Genton; J F Pellissier; J Roger
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-02       Impact factor: 10.154

5.  Is monoamine oxidase inhibitor induced myoclonus serotoninergically mediated?

Authors:  J J Askenasy; M D Yahr
Journal:  J Neural Transm       Date:  1988       Impact factor: 3.575

6.  Treatment of myoclonus with pheneturide.

Authors:  C D Ward
Journal:  J Neurol Neurosurg Psychiatry       Date:  1978-07       Impact factor: 10.154

7.  Postanoxic myoclonus. Treatment of a case with 5-hydroxytryptophane and a decarboxylase inhibitor.

Authors:  E Beretta; F Regli; G de Crousaz; A J Steck
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

8.  Coarse, jerky foot tremor: tremographic investigation of an objective sign of acute akathisia.

Authors:  W M Braude; I P Charles; T R Barnes
Journal:  Psychopharmacology (Berl)       Date:  1984       Impact factor: 4.530

9.  Myoclonic attacks induced by L-dopa and bromocryptin in Parkinson patients: a sleep EEG study.

Authors:  J Vardi; H Glaubman; J M Rabey; M Streifler
Journal:  J Neurol       Date:  1978-04-14       Impact factor: 4.849

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.